Search PubMed⌕ Search

Biomedical subjects

F Polatti

Publications and source records attributed to F Polatti.

49 records · Page 3Linked to original sources
PubMed1978

Lead in red blood cells and in plasma of pregnant women and their offspring.

Lead levels were measured in red blood cells and plasma of 75 pregnant women and their infants at delivery. No significant differences were found by comparing maternal and fetal values and a statistically significant positive correlation was evidenced, higher for plasma levels. The results suggest that the diffusible form of maternal lead in plasma influences the lead transferred to the fetus more directly. The highly significant correlation found between the maternal and fetal ratio of lead in plasma to lead in erythrocytes seems to be in favor of inborn factors influencing the equilibrium between the two compartments in which lead is distributed.

Erythrocytes↗
PubMedDate not supplied

Climacteric complaints, female identity, and sexual dysfunctions.

Forty early menopausal women seeking relief from sexual symptoms within a long-term marital relationship and 40 matched women seeking relief of climacteric complaints completed questionnaires concerning three subject: vasomotor and psychosocial symptoms, sexual dysfunctions, and female identity. Results showed that women with sexual dysfunctions were more likely to suffer from vasomotor and psychosocial complaints and their feminine identity was based mainly on ideals of motherhood and beauty. In addition, sexual desire disorders were present significantly in those women with higher psychosocial symptoms, while sexual arousal disorders were particularly evident in women suffering more vasomotor symptoms.

Climacteric↗
PubMedDate not supplied

[Calcium folate in pregnancy. Therapeutic efficacy].

An open, randomised multicentre study was carried out to compare pregnant women, treated with calcium folinate (Citofolin Bracco S.p.A.) 15 mg/day per os starting from the 12th or 20th week of gestation, with an untreated group. The results obtained confirm the efficacy of calcium folinate treatment on the trends of parameters analysed (serum and endoerythrocytic folatemia, hemoglobin and sideremia) which remained within the normal range. Moreover, no adverse effects of any type were reported during the study.

Calcium, Dietary↗
PubMedDate not supplied

[Treatment of ovariectomized patients with intramuscular and nasal-spray synthetic calcitonin].

The activity of different formulations of synthetic calcitonins on the prevention of bone loss was evaluated in young women after oophorectomy. In the 1st study patients were treated or with salmon calcitonin (CTs) intramuscularly (100 I.U. every second day; 10 patients) either with CTs nasal spray (100 I.U. daily; 10 patients). In the 2nd study patients received or CTs i.m. (100 I.U. every second day; 10 patients) either a synthetic analogue of eel calcitonin (eCT) given i.m. (80 I.U. every 2nd day; 10 patients). All calcitonins formulations were given for 9 months with oral calcium supplement (1 g daily). In the 1st study no significant changes of bone mineral content (BMC) was found at the end of the treatment in both groups. In the 2nd study a statistically significant decrease of BMC was observed in the group treated with eCT while non relevant changes were found in the CTs treated patients. Slight side effects were observed in some patients treated with calcitonin formulations given i.m. Since salmon calcitonin nasal spray was well tolerated and prevented bone loss after oophorectomy its use might be recommended in the treatment of postmenopausal osteoporosis.

Adult↗